Publicaciones (91) Publicaciones de JOSE LUIS MAURIZ GUTIÉRREZ

2024

  1. Anti-retinal Antibodies in Sarcoidosis

    Ocular Immunology and Inflammation, Vol. 32, Núm. 2, pp. 141-147

  2. Aprendizaje-Servicio en el entorno rural de León

    Innovación docente en la Universidad de León (Servicio de Publicaciones), pp. 165-172

  3. Correction to: Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway (Nutrients, (2017), 9, 3, (288), 10.3390/nu9030288)

    Nutrients

  4. Corrigendum: Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells (Journal of Cellular Physiology, 10.1002/jcp.26855)

    Journal of Cellular Physiology

  5. Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study

    Journal of Gastrointestinal Oncology, Vol. 15, Núm. 3, pp. 1072-1081

  6. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

  7. Strategies to enhance the response of liver cancer to pharmacological treatments

    American journal of physiology. Cell physiology, Vol. 327, Núm. 1, pp. C11-C33

2023

  1. Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)

    Cancers

  2. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation

    Acta Pharmacologica Sinica, Vol. 44, Núm. 5, pp. 1066-1082

  3. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity

    Cells, Vol. 12, Núm. 8

  4. Neuropilins as potential biomarkers in hepatocel-lular carcinoma: a systematic review of basic and clinical implications

    Clinical and Molecular Hepatology, Vol. 29, Núm. 2, pp. 293-319

  5. Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)

    Chinese Clinical Oncology

2022

  1. Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence

    Journal of Cellular Physiology, Vol. 237, Núm. 7, pp. 2740-2757

  2. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

    Cancers, Vol. 14, Núm. 14

  3. Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies

    Cancers, Vol. 14, Núm. 14

2021

  1. Association of foxo3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: A systematic review with meta-analysis

    Cancers, Vol. 13, Núm. 21

  2. Autophagy-related chemoprotection against sorafenib in human hepatocarcinoma: Role of foxo3 upregulation and modulation by regorafenib

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

    Aging, Vol. 13, Núm. 19, pp. 23416-23434

  5. Inhibidores tirosín quinasa en el tratamiento del hepatocarcinoma avanzado

    AmbioCiencias: revista de divulgación, Núm. 19, pp. 107-118